NOX4, a new genetic target for anti-cancer therapy in digestive system cancer

Area of Science:

• Biochemistry
• Oncology
• Molecular Biology

Background:

• Oxidative stress is a key factor in cancer development and progression.
• Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunit 4 (NOX4) generates reactive oxygen species (ROS) and is upregulated in gastrointestinal tumors.

Purpose of the Study:

• To review the biological role of NOX4 in digestive system tumors.
• To explore NOX4's connections with key cell signaling pathways and mediators.
• To assess NOX4's prognostic and therapeutic potential in gastrointestinal cancers.

Main Methods:

• Literature review of clinical, database, and animal studies.
• Analysis of NOX4 expression correlation with signaling pathways (VEGF, MAPK, PI3K/AKT) and mediators (NF-κB, AP-1, TGF-β).
• Evaluation of NOX4 inhibitors (diphenylene iodonium, GKT137831) in preclinical models.

Main Results:

• NOX4 expression is significantly associated with tumor prognosis and patient survival in colorectal, gastric, and pancreatic cancers.
• NOX4 interacts with established cancer-related signaling pathways and transcription factors.
• NOX4 inhibitors demonstrate therapeutic potential against cancer cells in animal studies.

Conclusions:

• NOX4 plays a critical role in the tumorigenesis and progression of digestive system cancers.
• Targeting NOX4 represents a promising therapeutic strategy for gastrointestinal malignancies.
• Further research into NOX4 inhibitors could lead to novel cancer treatments.